Why is Parmax Pharma falling/rising?

As of 15-Oct, Parmax Pharma Ltd's stock price is currently at Rs. 34.50, reflecting an increase of Rs. 2.7 or 8.49%. The stock has shown significant volatility today, with an intraday high of Rs. 34.5 and a low of Rs. 29.9, marking a wide trading range of Rs. 4.6. Despite hitting a new 52-week low earlier in the day, the stock has outperformed its sector by 8.41%. Over the past week, Parmax Pharma has experienced a return of +12.38%, while its year-to-date performance remains negative at -22.03%. Notably, investor participation has declined, with delivery volume dropping by 71.46% compared to the 5-day average, indicating a potential concern regarding sustained interest in the stock.
Broader Market Context: In comparison to the benchmark Sensex, which has returned +1.02% over the past week, Parmax Pharma's performance has significantly outpaced it. This suggests that while the stock is experiencing a positive short-term movement, its longer-term performance remains concerning, as evidenced by its year-to-date decline of -22.03% against the Sensex's +5.72%. The stock's current trading dynamics, including high volatility and a liquidity level sufficient for trading, indicate that while there may be short-term gains, the overall market sentiment towards Parmax Pharma remains cautious, particularly given its historical performance over the past year and beyond.